We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.39%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$18.8B
AUM Growth
–
Cap. Flow
+$18.6B
Cap. Flow
% of AUM
98.77%
Top 10 Holdings %
Top 10 Hldgs %
14.87%
Holding
1,277
New
1,254
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$355M |
| 2 |
Apple
AAPL
|
+$344M |
| 3 |
Chevron
CVX
|
+$323M |
| 4 |
JPMorgan Chase
JPM
|
+$296M |
| 5 |
ExxonMobil
XOM
|
+$285M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.07% |
| 2 | Financials | 12.69% |
| 3 | Technology | 11.8% |
| 4 | Energy | 9.95% |
| 5 | Industrials | 8.65% |
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Axa, which disclosed 1,277 positions worth $18.8B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Pfizer: 12,852,527 shares worth $342M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Financials and Technology.
- Axa's largest Q2 2013 buy was Pfizer: 12,852,527 shares worth $342M.
- Axa's ten largest holdings make up 15% of its $18.8B portfolio in Q2 2013.
- Axa disclosed 1,277 positions in Q2 2013, its first 13F filing on record.
Based on Axa's 13F filing for Q2 2013, filed 12 Aug 2013.